offered to the public. obtaining liquidity and accelerating its growthand one year after its debut in the SME market, BME Growth, the numbers confirm that they are on the right track. Vytrus Biotech closes 2022 with record revenue and 34% more profit. Specifically, this company specializes in: active ingredients derived from plant stem cells for the cosmetic industryIt closes the year with a turnover of 3.7 million euros (31% more than in 2021) and a net profit of 605,000 euros.
Thus, this year marks the sixth consecutive year that the company has grown by an average of over 30%, despite a 65% increase in billing in 2021.
“Returning to more than 30% growth in sales and profits in a complex financial year like 2022 means that power and business model scalability Vytrus Biotech”, valued co-founder and chief operating officer of the company, Albert Jane.
Among other things, as summarized in the statement made by the company, it was stated that the company managed to spread to 5 continents and 66% of its revenues came from overseas sales. In addition, as highlighted in the same text, it is also Co-founder and director of Vytrus, Oscar FairThe year also leaves them with the issuance of a triple patent. Europe, United States of America And Japan “reinforces the company’s commitment to pioneering technological innovation and setting trends in the cosmetics industry”.
stock growth
In the stock market, Vytrus is also gathering good news. In the nine months it was listed, the company’s market capitalization increased from €12 million to €24 million. To date, the majority of the company is owned by its founders and various private investors. Zamit Capital Fund (having 7.9%), Catalan Institute of Finance (another 6.2% amount) and Julia Perfumery Group (5.4%). In other words, small investors own 40% of the company.
“This improvement in share value reflects the well-received market response of Vytrus, and even more so in the current uncertainty that stock markets are experiencing globally,” in fact, the 5 depreciating companies conclude. 0.2% on the ground so far in 2023.